Literature DB >> 3020376

Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.

J Yamagishi, H Yoshida, M Yamayoshi, S Nakamura.   

Abstract

DNA fragments of 3.4 kb containing the gyrB gene were cloned from Escherichia coli KL-16 and from spontaneous nalidixic acid-resistant mutants. The mutations (nal-24 and nal-31) had been determined to be in the gyrB gene by transduction analysis. Nucleotide sequence analysis of the cloned DNA fragments revealed that nal-24 was a G to A transition at the first base of the 426th codon of the gyrB gene, resulting in an amino acid change from aspartic acid to asparagine, and nal-31 was an A to G transition at the first base of the 447th codon, resulting in an amino acid change from lysine to glutamic acid. This indicates tha mutations in the gyrB gene are responsible for nalidixic acid resistance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020376     DOI: 10.1007/bf00331012

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  35 in total

1.  Characterization of the dnaA, gyrB and other genes in the dnaA region of the Escherichia coli chromosome on specialized transducing phages lambda tna.

Authors:  F G Hansen; K von Meyenburg
Journal:  Mol Gen Genet       Date:  1979-09

2.  Cloning and physical mapping of the dnaA region of the Escherichia coli chromosome.

Authors:  T Miki; M Kimura; S Hiraga; T Nagata; T Yura
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

3.  The nature of the transformation process in Escherichia coli K12.

Authors:  S D Cosloy; M Oishi
Journal:  Mol Gen Genet       Date:  1973-07-31

4.  Formation of merodiploids in matings with a class of Rec- recipient strains of Escherichia coli K12.

Authors:  B Low
Journal:  Proc Natl Acad Sci U S A       Date:  1968-05       Impact factor: 11.205

5.  New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.

Authors:  J Yamagishi; Y Furutani; S Inoue; T Ohue; S Nakamura; M Shimizu
Journal:  J Bacteriol       Date:  1981-11       Impact factor: 3.490

6.  Molecular analysis of the recF gene of Escherichia coli.

Authors:  M A Blanar; S J Sandler; M E Armengod; L W Ream; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  The nucleotide sequence of the dnaA gene and the first part of the dnaN gene of Escherichia coli K-12.

Authors:  E B Hansen; F G Hansen; K von Meyenburg
Journal:  Nucleic Acids Res       Date:  1982-11-25       Impact factor: 16.971

8.  Characterization of dnaA gene carried by lambda transducing phage.

Authors:  A Murakami; H Inokuchi; Y Hirota; H Ozeki; H Yamagishi
Journal:  Mol Gen Genet       Date:  1980

9.  Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.

Authors:  S Inoue; T Ohue; J Yamagishi; S Nakamura; M Shimizu
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

10.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

View more
  105 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.

Authors:  J Okuda; E Hayakawa; M Nishibuchi; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.

Authors:  S Nakamura; M Nakamura; T Kojima; H Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

4.  Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus.

Authors:  K Ubukata; N Itoh-Yamashita; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding.

Authors:  J E Lindsley; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

6.  Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.

Authors:  B L Masecar; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

7.  In vitro activity of AT-4140 against clinical bacterial isolates.

Authors:  T Kojima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.

Authors:  L M Weigel; G J Anderson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 9.  Mechanisms of resistance to quinolones.

Authors:  E Cambau; L Gutmann
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 10.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.